By dekiley

Department of Pathology & Laboratory Medicine: New News Summer 2020

September 2nd, 2020 in Uncategorized

Department of Pathology & Laboratory Medicine:

New News Summer 2020


During the 2020 SARS CoV-2 pandemic Pathology Laboratory Sciences graduate students past and present stepped up to support the department in a major way. Manisha Cole (GMS 2021) and recent graduates Kyle de la Cena (GMS 2020) and Morgan Thompson (2017) have been instrumental in setting up and supporting the BMC-BU Covid 19 biobank initiative, led by faculty member Assistant Professor Elizabeth R Duffy (GMS 2009).  This team has processed thousands of discarded human biospecimens to ensure that sufficient Cov-2 related material is available to research scientists.  Some of this material was also used by the BU SARS CoV-2  testing laboratory during set up and validation of their test.  In addition, this team is supporting a longitudinal study of patients with Covid infection funded by the Mass Consortium on Pathogen Readiness (PI Nahid Bhadelia, MD).

Additionally on a project led by Assistant Professor in Pathology & Laboratory Medicine and student mentor Yachana Kataria, PhD, Liz Duffy, Manisha Cole and Kyle de la Cena prepared, initiated and led two hospital wide SARS Cov-2 seroprevalance studies called SIG-COV (PI Yachana Kataria) and STOP (PI Karen Jacobson). Over 1,700 employees registered to have their blood drawn and antibodies tested. Along with members of the BMC and BU pathology department students Richard Darko (GMS 2021), Victoria Gibson (GMS 2021) and  Tochukwu “Nola” Ihejirika (GMS 2021) supported the initiative during an intense two week period of recruiting and collecting from volunteer subjects.

Cheryl Spencer (GMS 2007) received special recognition at the 2020 graduation awards ceremony for her outstanding work supporting the autopsy service during the surge. Morgan Thompson (2017) also supported the SARS Cov-2 pcr testing during the pandemic surge.

Chris Andry, MPhil, PhD

Professor and Chair

Department of Pathology & Laboratory Medicine

Boston University School of Medicine


  • Boston University Clinical and Translational Science Institute (BU CTSI) has been selected to receive funding.
Proposal Title:   3D Printed COVID-19 Nasopharyngeal Swabs
Principal Investigator:   Alice White, PhD

Project has been led by a graduate student, Jessie Soong in the School of Bioengineering at BU CRC. Pathology & Lab Medicine participants include Drs Henderson, Miller, Fazeli, Andry and Beverley Orr and the Microbiology team.

Dear Dr. White:

Congratulations, we are pleased to inform you that your COVID-19 Related Research application to the Boston University Clinical and Translational Science Institute (BU CTSI) has been selected to receive funding. Based on available funding and the submitted budget for your project, you will receive total of $24,999.00 in direct costs. The project period for this award is June 1, 2020-March 31, 2021.

The BU CTSI is funded by a Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health, and grant UL1TR001430. For more details regarding CTSI supported resources and services, please navigate to the BU CTSI Website at 

Anna Belkina, MD, PhD has been awarded CTSI Funds for a Mini Sabbatical Dr. Belkina will use the mini-sabbatical funds to support her advanced training in high-parameter imaging data analysis at the Flow Cytometry and Cellular Imaging Facility (FCCIF) at the University of Texas MD Anderson Cancer Center.


 Dear Colleagues,

  • On behalf of Dr Dennis Jones and the department I am really pleased to welcome Dr Samir Jana.  Dr Jana is from Kolkata, India. He obtained a Masters degree in Molecular Biology and Biotechnology from the University of Kalyani, India. He earned a PhD from the University of Calcutta and worked on the thesis topic “Regulation of miRNA in Breast Cancer Growth and Metastasis. Dr Jana continued his training as a postdoctoral researcher at City of Hope, California and worked on ER stress/autophagy pathway and chemosensitization of breast cancer.  In the Jones lab, he intends to study cancer stem cell maintenance and immune evasion during breast cancer progression. Dr Jana enjoys travelling, photography, cooking and playing cricket.


Please join me in welcoming him.




Christopher Heaphy, PhD, Assistant Professor of Medicine (Hematology & Oncology Section)  appointment asAssistant Professor of Pathology & Laboratory Medicine

  • Dr. Heaphy is a cancer biologist that has been conducting basic and translational studies focused on elucidating the role of telomere alterations in the initiation of human diseases, particularly cancer. Overall, his research program focuses on cancer biomarker discovery and validation with the ultimate aim to utilize novel tissue-based biomarkers to improve individualized prevention, detection, and treatment strategies. Dr. Heaphy received a Ph.D. from the University of New Mexico and completed his post-doctoral training in the Department of Pathology at Johns Hopkins School of Medicine. He is a recognized expert on telomere biology and its associations with cancer outcomes. He has authored over 70 papers, including a transformative study published in Science that uncovered the association between inactivating mutations in ATRX and DAXX and activation of a unique telomerase independent telomere maintenance mechanism. Subsequently, he has further expanded his work to include a wide range of malignancies (e.g. prostate cancer, breast cancer, gliomas, and neuroendocrine tumors).


Please join me in welcoming Dr Heaphy to the department. ~ Chris




  • Also Welcome New Incoming Masters Students:
    • Sarah Faress Barakat
    • James Ford
    • Jamail Ghafwari
    • Jordyn Osterland
    • Kevin Rop
    • Lila Sultan
    • Anna Tseng
    • Meng Wei “Winnie” Zhang
    • Qiuyang Zhang
    • Also, Razi Amraei is joining the department as a PhD Candidate

Welcome to Allan Stolarski is a new Surgery resident working in the Remick Lab starting from the 1stday of July

Faculty Promotions to Associate Professor: Joel Henderson

The Hematology Lab and DG-LIS (Angel) – The SYSMEX is live!!!!!  Wooo hoooo




Our Residents took theses pictures Friday, July 24th during the BMC Thank You Week



Daniel Remick, M.D., has been selected to serve as a Reviewing Editor for the journal Science Translational Medicine.  This is a prestigious journal with a very high impact factor (17.2). He will be responsible for reviewing articles on sepsis

Masis Parunyan (MED IV) was one of this years recipients of the ASCP Medical Student Award for Pathology



A review article for Daniel Remick, M.D., reached a milestone when it was read 1000 times.Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry, May 2000, 157: 683-694.

Publications. Published:

  • Kim Vanuytsel, Aditya Mithal, Richard M. Giadone, Anthony K. Yeung, Taylor M. Matte, Todd W. Dowrey, Rhiannon B. Werder, Gregory J. Miller,Nancy S. Miller, Christopher D. Andry, George J. Murphy. Rapid Implementation of a SARS-CoV-2 Diagnostic qRT-PCR Test with Emergency Use Authorization at a Large Academic Safety-Net Hospital. Clinical and Translational Resource and Technology Insights, May 2020
  • Matthew Wolfson,1 Patrick Curtin,2; Emily J. Curry,3; Sandra Cerda,4; Xinning Li1; “Giant cell tumor formation due to metallosis after open latarjet and partial shoulder resurfacing.” Orthopedic Reviews 2020; volume 12:8522

      Publications. Accepted:

  • A recent review article was just accepted in the journal Shock, Yibing Wei, Jiyoun Kim, Harri Ernits and Daniel Remick, “The Septic Neutrophil – Friend or Foe” Yibing Wei recently completed her Masters of Science degree in the Department


Department of Pathology & Laboratory Medicine: New News Spring 2020

May 29th, 2020 in Uncategorized

Please find below a summary of reported activities in the department. As Summer approaches we are emerging from a most remarkable experience of dealing with the SARS Cov-2 pandemic.  Our clinical laboratory team: Lab Medicine, Pathology and colleagues in the CReM brought clinical testing forward to support the hospital, in record time.  The group worked tirelessly to ensure we provided the best service possible to our patients and colleagues.  Our Cov autopsy team worked bravely, under challenging circumstances, to perform post-mortem studies and collect important tissue samples for research.  Our department is also actively engaged in archiving biospecimens to be made available for research and future equipment validation.

While these particular efforts have been ongoing, our department has also continued to provide outstanding clinical service, formal teaching, mentorship and research initiatives.

 I wish you all well and thank everyone for their hard work and commitment

– best wishes Chris Andry.


  • Please welcome our new 2020- 2021 residents: Drs. Claire Avillach, Sanket Chosi, Isabela Pereira, Lubna Suaiti and Katie Doonan.
  • Tao Zuo, MD, PhD joined us from UMass and is a new pathology faculty member in the practice and assistant professor of Pathology & Laboratory Medicine
  • Lan Zhou, MD, PhD is vice chair for research, neurology and professor for Neurology and, Pathology and Laboratory Medicine, she is also a new member of our department and performs subspecialty work on nerve and muscle biopsies
  • Samir Jana, PhD, as a postdoctoral fellow in Dr. Dennis’s lab, beginning May 18th.
  • Weining Lu, MD, MSwas named 2019 Boston University Innovator of the Year:
  • Dennis Jones, Ph.D., Assistant Professor of Pathology & Laboratory Medicine, has been selected as the inaugural early career representative to the FASEB Board of Directors.  FASEB represents over 130,000 researchers from across the world and has become recognized as the policy voice for biological researchers. Dr. Jones’s selection to serve on the FASEB board recognizes his status as early investigator who will contribute to the direction of scientific studies.
  • Daniel Remick, M.D., chaired an NIH study section to review K38 grants. K38 grants are a new mechanism to help create clinician-scientists, Stimulating Access to Research in Residency Transition Scholar (StARRTS)
  • Also Daniel Remick, M.D. was awarded an NIH grant, R21AI 147168 “Mechanisms of improved organ function following sepsis treatment with vitamin c, thiamine and hydrocortisone (triple therapy)”
  • Lan Zhou is excited to share a good news with you, her pathology book "A Case-Based Guide to Neuromuscular Pathology" has been published by Springer! job affiliation. A Case-Based Guide to Neuromuscular Pathology: Lan Zhou: Springer


  • Erin Norberg has accepted the promotion to Assistant Supervisor in Point of Care
  • Please welcome Brad Couture in his new role of Assistant Supervisor, Microbiology
  • Stacia Cote, was promoted to Assistant Supervisor, Cytology
  • A research publication by Daniel Remick, M.D. reached a milestone in April 2020 when it was cited for the 400th The article: Six at six: Interleukin 6 measured 6 hours after the initiation of sepsis predicts mortality over 3 days was published in the journal Shock in May of 2002.
  • Research Awards from the Massachusetts Consortium on Pathogen Readiness BMC is the recipient of two awards, totaling $619,000, from the Massachusetts Consortium on Pathogen Readiness (MassCPR) to fund research projects focused on COVID-19. George Murphy, PhD, co-director of the Center for Regenerative Medicine (CReM), Chris Andry, MPhil, PhD, chief of pathology and laboratory medicine at BMC, and Nancy Miller, MD, chief and vice chair of laboratory medicine at BMC, in collaboration with CReM faculty researchers, will lead a project aimed at reducing the rates of false negative COVID-19 test results. Using machine learning, the team will develop an algorithm to interpret test results more quickly and accurately than current methods. The team will also develop new methods for pooling samples to increase testing speed.
  • From Weining Lu; our recent publicationhas been selected as an Editor’s Choice article on The American Journal of Pathology (See Editor-in-Chief Dr. Martha Furie’s email below and the article online: In addition, there is a news release from BUSM about this work:
  • Lawreen Connors, PhD, Professor of Pathology & Laboratory Medicine, has been named the Charles J. Brown Research Professor in Amyloidosis, effective July 1, and established by the estate of Charles J. Brown.

Congratulation Class of 2020

  • Residents
    • Shoreh Fazeli, MD; Dr Fazeli will be moving on to the Beth Israel Deaconess Hospital for  a General Surgical Pathology Fellowship
    • Andrey Prilutskiy, MD; Dr Prilutskiy will be at Mass General hospital for a Head and Neck Pathology Fellowship
    • Weiwei Shi, MD: Dr Shi will next be moving to Brigham Women Hospital for the Thoracic Pathology fellowship
  • Masters Graduates
    • Marcela Alvia, MS; is staying on at the VA to finish work for publication
    • Amanda Araujo, MS: Amanda’s future plans include maintaining employment at MGH in the Surgical Pathology department for the near future, and looking forward she is planning on applying to medical school in hopes of becoming a Forensic Pathologist. The only solid plan for now is working at her job and studying for the MCAT
    • Julia Breda Camessola, MS: She is hoping that the Sarah Mazzilli Lab will hire her for a little bit as she has to finish up experiments for a publication that she is co-authoring. After that is done, Julia’s goal is to find a job in clinical research in which allows her to do both bench work but to also have patient contact
    • Kyle de le Cena, MS: Kyle is working at BMC in Pathology as a Research Associate for Biospecimen Science
    • Kunlin Huang, MS: She is moving back home to China over the summer and finding work in a clinical lab
    • Claire Marcus, MS: Unknown at this time
    • Grace Marden, MS: Has been Promoted to Lab Manager in Dr. Maria Trojanowska’s Lab
    • Linzi Sun, MS: Linzi will be moving back home to China over the summer and finding work
    • Hoang Thang, MS: Hoang is applying for a job in Boston as OPT
  • Jessica Kenison-White, PhD Candidate (Sherr Lab) was a recipient of a first prize award at the 26thAnnual H. I. Russek Student Achievement Day. Congratulations!
  • The #ProtectYourCaregiver group hosted a very successful online art auction, raising over $44,000 for BMC frontline staff. Thank you to the group and their committee for putting together such an effort for BMC. The committee included BMC clinician Claire Avillach,  MD, MS Renal fellow, Instructor of Medicine (Incoming Pathology Resident)

Publications. Published:

  • Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis.Staron A, Burks EJ, Lee JC, Sarosiek S, Sloan JM, Sanchorawala V.Blood Adv. 2020 Mar 10;4(5):880-884. doi: 10.1182/bloodadvances.2019001331.PMID
  • Authors: Alexandra Rachel Greenberg*, Bertrand Russel Huber†, David Xianhong Liu‡, James Patrick Logue‡, Amanda Marie Woolsey Hischak‡, Randy Hart, Maureen Abbott‡, Nejra Isic‡, Yohei Michael Hisada, Nigel Mackman§, Richard Scott Bennet‡, Lisa E Hensley‡, John Hazard Connor: entitled “Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: a Longitudinal Study of Zaire Ebolavirus strain Kikwit (EBOV/Kik) The American Journal of Pathology
  • Bharath LP, Agrawal M, McCambridge G, Nicholas DA, Hasturk H, Liu J, Jiang K, Liu R, Guo Z, Deeney J, Apovian CM, Snyder-Cappione J, Hawk GS, Fleeman RM, Pihl RMF, Thompson K, Belkina AC, Cui L, Proctor EA, Kern PA, Nikolajczyk BS. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell Metab. 2020 May 5;. Doi: 10.1016/j.cmet.2020.04.015. [Epub ahead of print] PubMed PMID: 32402267
  • Belkina AC, Azer M, Lee JJ, Elgaali HH, Pihl R, Cleveland M, Carr J, Kim S, Habib C, Hasturk H, Snyder-Cappione JE, Nikolajczyk BS.  Single-Cell Analysis of the Periodontal Immune Niche in Type 2 Diabetes. J Dent Res. 2020 Mar 18;:22034520912188. doi: 10.1177/0022034520912188. [Epub ahead of print] PubMed PMID: 32186942
  • Guillon A, Arafa EI, Barker KA, Belkina AC, Martin I, Shenoy AT, Wooten AK, Lyon De Ana C, Dai A, Labadorf A, Hernandez Escalante J, Dooms H, Blasco H, Traber KE, Jones MR, Quinton LJ, Mizgerd JP.  Pneumonia recovery reprograms the alveolar macrophage pool. JCI Insight. 2020 Feb 27;5(4). doi: 10.1172/jci.insight.133042. PubMed PMID: 31990682; PubMed Central PMCID: PMC7101156
  • Zhang W, Ji T, Lyon S, Mehta M, Zheng Y, Deng X, Liu A, Shagan A, Mizrahi B, Kohane DS. Functionalized Multiarmed Polycaprolactones as Biocompatible Tissue Adhesives. ACS Appl Mater interfaces. 2020 Apr 15;12(15):17314-17320
  • Zhang W, Ji T, Li Y, Zheng Y, Mehta M, Zhao C, Liu A, and Kohane DS. Light-triggered release of conventional local anesthetics from a macromolecular prodrug for on-demand local anesthesia. Nat Commun. 2020 May 8;11(1):2323

Publication. Accepted:

  • Anna Pisarek-Horowitz, Xueping Fan, Sudhir Kumar, Hila Milo Rasouly, Richa Sharma,Hui Chen, Kathryn Coser, Crystal T. Bluette, Dinesh Hirenallur-Shanthappa, Sarah R. Anderson, Hongying Yang, Laurence H. Beck, Jr, Ramon G. Bonegio, Joel M. Henderson, Stephen P. Berasi, David J. Salant, Weining Lu. Loss of Robo2 in podocytes protects adult mice from glomerular injury by maintaining podocyte foot process structure. The American Journal of Pathology, 2020. in press
  • ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule" was accepted for publication at Authors include: Shoreh R Fazeli, Brad Zehr, Razie Amraei, Gianluca Toraldo, Haixia Guan, David Kindelberger, Stephanie Lee, Sandra Cerda
  • Jones.PhD, Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy:


COVID-19 Essential Service: March 23, 2020

March 23rd, 2020 in Uncategorized

March 23, 2020

Governor Charlie Baker issued an emergency order requiring all businesses and organizations that do
not provide “COVID-19 Essential Services” to close their physical workplaces and facilities to workers,
customers and the public as of Tuesday, March 24th at noon until Tuesday, April 7th at noon. These
businesses are encouraged to continue operations remotely.
The Baker-Polito Administration issued a list of designated businesses and other organizations that
provide essential services and workforces related to COVID-19 that shall continue to operate brick and
mortar facilities during this two-week time period. This list is based on federal guidance and amended to
reflect the needs of Massachusetts’ unique economy. While these businesses are designated as
essential, they are urged to follow social distancing protocols for workers in accordance with guidance
from the Department of Public Health.
Businesses and organizations not on the list of essential services are encouraged to continue operations
through remote means that do not require workers, customers, or the public to enter or appear at the
brick-and-mortar premises closed by the order.
Restaurants, bars, and other establishments that sell food and beverage products to the public are
encouraged to continue to offer food for take-out and by delivery if they follow the social distancing
protocols set forth in Department of Public Health guidance continue operations. On-premises
consumption of food or drink is prohibited.
• Workers providing COVID-19 testing; Workers that perform critical clinical research needed for
COVID-19 response
• Medical Professionals and caregivers (e.g., physicians, dentists, psychologists, mid-level
practitioners, nurses and assistants, infection control and quality assurance personnel,
pharmacists, physical and occupational therapists and assistants, social workers, speech
pathologists and diagnostic and therapeutic technicians and technologists, other providers of
mental and behavioral health care, personal care attendants, home health aides and home care
• Hospital and laboratory personnel (including accounting, administrative, admitting and
discharge, engineering, epidemiological, source plasma and blood donation, food service,
housekeeping, medical records, information technology and operational technology,
nutritionists, sanitarians, respiratory therapists, etc.)
• Workers in other medical facilities (including Ambulatory Health and Surgical, Blood Banks,
Medical Clinics, Community Mental Health Centers, Methadone/OBOT Clinics, 24 hour
Diversionary and Residential Behavioral Health Providers, Comprehensive Outpatient
rehabilitation, End Stage Renal Disease, Health Departments, Home Health care, Hospices,
Hospitals, Nursing Facilities, Rest Homes, Assisted Living Residences, Organ Pharmacies,
COVID-19 Essential Services
March 23, 2020
Procurement Organizations, Psychiatric Residential, Residential Treatment Schools, Rural Health
Clinics and Federally Qualified Health Center s and Community Health Centers, State Hospitals,
and licensed medical marijuana retailers)
• Workers in other 24/7 community resident services serving children and youth, and individuals
with developmental, intellectual, physical and/or cognitive disabilities
• Manufacturers, technicians, logistics and warehouse operators, and distributors of or necessary
to the supply chain of medical equipment, personal protective equipment (PPE), medical gases,
pharmaceuticals, blood and blood products, vaccines, testing materials, laboratory supplies,
cleaning, sanitizing, disinfecting or sterilization supplies, and tissue and paper towel products
• Public health / community health workers, including those who compile, model, analyze and
communicate public health information
• Blood and plasma donors and the employees of the organizations that operate and manage
related activities
• Workers that manage health plans, billing, and health information, who cannot practically work
• Workers who conduct community-based public health functions, conducting epidemiologic
surveillance, compiling, analyzing and communicating public health information, who cannot
practically work remotely
• Workers performing cybersecurity functions at healthcare and public health facilities, who
cannot practically work remotely
• Workers conducting research critical to COVID-19 response
• Workers performing security, incident management, and emergency operations functions at or
on behalf of healthcare entities including healthcare coalitions, who cannot practically work
• Workers who support food, shelter, and social services, and other necessities of life for
economically disadvantaged or otherwise needy individuals, such as those residing in shelters
• Pharmacy employees necessary for filling prescriptions
• Workers performing mortuary services and workers at funeral homes, crematoriums, and
• Workers who coordinate with other organizations to ensure the proper recovery, handling,
identification, transportation, tracking, storage, and disposal of human remains and personal
effects; certify cause of death; and facilitate access to mental/behavioral health services to the
family members, responders, and survivors of an incident
• Personnel in emergency management, law enforcement, Emergency Management Systems, fire,
and corrections, including front line and management required to maintain operations
• Emergency Medical Technicians
• 911 call center employees, including telecommunicators, dispatchers and managers
• Fusion Center employees
• Hazardous material responders from government and the private sector.
• Workers – including contracted vendors -- who maintain digital systems infrastructure
supporting law enforcement and emergency service operations.
• Workers supporting groceries, pharmacies and other retail, including farmers markets and farm
stands, that sells food and beverage products, including liquor stores
• Restaurant carry-out and quick serve food operations - Carry-out and delivery food employees
COVID-19 Essential Services
March 23, 2020
• Food manufacturer employees and their supplier employees—to include those employed in
food processing (packers, meat processing, cheese plants, milk plants, produce, etc.) facilities;
livestock, poultry, seafood slaughter facilities; pet and animal feed processing facilities; human
food facilities producing by-products for animal food; beverage production facilities; and the
production of food packaging
• Farm workers to include those employed in animal food, feed, and ingredient production,
packaging, and distribution; manufacturing, packaging, and distribution of veterinary drugs;
truck delivery and transport; farm and fishery labor needed to produce our food supply
• Farm workers and support service workers to include those who field crops; commodity
inspection; fuel ethanol facilities; storage facilities; and other agricultural inputs
• Workers supporting the seafood and fishing industry
• Employees and firms supporting food, feed, and beverage distribution, including warehouse
workers, vendor-managed inventory controllers and blockchain managers
• Workers supporting the sanitation of all food manufacturing processes and operations from
wholesale to retail
• Company cafeterias - in-plant cafeterias used to feed employees; food service workers in
residential schools with students who are unable to leave campus
• Workers in food testing labs in private industries and in institutions of higher education
• Workers essential for assistance programs and government payments
• Employees of companies engaged in the production of chemicals, medicines, vaccines, and
other substances used by the food and agriculture industry, including pesticides, herbicides,
fertilizers, minerals, enrichments, and other agricultural production aids
• Animal agriculture workers to include those employed in veterinary health; manufacturing and
distribution of animal medical materials, animal vaccines, animal drugs, feed ingredients, feed,
and bedding, etc.; transportation of live animals, animal medical materials; transportation of
deceased animals for disposal; raising of animals for food; animal production operations;
slaughter and packing plants and associated regulatory and government workforce
• Organizations and workers responsible for the care and custody of animals, pets and livestock
• Workers who support the manufacture and distribution of forest products, including, but not
limited to timber, paper, and other wood products
• Employees engaged in the manufacture and maintenance of equipment and other infrastructure
necessary to agricultural production and distribution
Electricity industry:
• Workers who maintain, ensure, or restore the reliable generation, transmission, and distribution
of electric power, including call centers, utility workers, reliability engineers and fleet
maintenance technicians
• Workers needed for safe and secure operations at nuclear generation
• Workers at generation, transmission and electric blackstart facilities
• Workers at Reliability Coordinator (RC), Balancing Authorities (BA), and primary and backup
Control Centers (CC), including but not limited to independent system operators, regional
transmission organizations, and balancing authorities
• Mutual assistance personnel
COVID-19 Essential Services
March 23, 2020
• IT and OT technology staff – for EMS (Energy Management Systems) and Supervisory Control
and Data Acquisition (SCADA) systems, and utility data centers; Cybersecurity engineers;
cybersecurity risk management
• Vegetation management crews and traffic workers who support
• Environmental remediation/monitoring technicians
• Instrumentation, protection, and control technicians
Petroleum workers:
• Petroleum product storage, pipeline, marine transport, terminals, rail transport, road transport
• Crude oil storage facilities, pipeline, and marine transport
• Petroleum refinery facilities
• Petroleum security operations center employees and workers who support emergency response
• Petroleum operations control rooms/centers
• Petroleum drilling, extraction, production, processing, refining, terminal operations,
transporting, and retail for use as end-use fuels or feedstocks for chemical manufacturing
• Onshore and offshore operations for maintenance and emergency response
• Retail fuel centers such as gas stations and truck stops, and the distribution systems that
support them
Natural and propane gas workers:
• Natural gas transmission and distribution pipelines, including compressor stations, and road
• Underground storage of natural gas
• Natural gas processing plants, and those that deal with natural gas liquids
• Liquefied Natural Gas (LNG) facilities
• Natural gas security operations center, natural gas operations dispatch and control
rooms/centers natural gas emergency response and customer emergencies, including natural
gas leak calls
• Drilling, production, processing, refining, and transporting natural gas for use as end-use fuels,
feedstocks for chemical manufacturing, or use in electricity generation
• Propane gas dispatch and control rooms and emergency response and customer emergencies,
including propane leak calls
• Propane gas service maintenance and restoration, including call centers
• Processing, refining, and transporting natural liquids, including propane gas, for use as end-use
fuels or feedstocks for chemical manufacturing
• Propane gas storage, transmission, and distribution centers
Steam workers:
• Workers who support steam distribution companies’ provision of district heating and any
electric generation
• Workers who support steam distribution companies’ dispatch and control rooms and
emergency response and customer emergencies, including steam leak calls
• Workers who support steam distribution companies’ service maintenance and restoration,
including call centers
• Workers who support steam distribution companies’ storage, transmission, and distribution
COVID-19 Essential Services
March 23, 2020
Employees needed to operate and maintain public and private drinking water and wastewater/drainage
infrastructure, including:
• Operational staff at water authorities
• Operational staff at community water systems
• Operational staff at wastewater treatment facilities
• Workers repairing water and wastewater conveyances and performing required sampling or
• Operational staff for water distribution and testing
• Operational staff at wastewater collection facilities
• Operational staff and technical support for SCADA Control systems
• Chemical disinfectant suppliers for wastewater and personnel protection
• Workers that maintain digital systems infrastructure supporting water and wastewater
• Employees supporting or enabling transportation functions, including dispatchers, maintenance
and repair technicians, warehouse workers, truck stop and rest area workers, and workers that
maintain and inspect infrastructure (including those that require cross-border travel)
• Employees of firms providing services that enable logistics operations, including cooling, storing,
packaging, and distributing products for wholesale or retail sale or use
• Mass transit and passenger rail workers, including contracted vendors providing transportation
and maintenance services to public transit authorities
• Workers critical to operating rental car companies and Transportation Network Companies
(TNCs) that facilitate continuity of operations for essential workforces, and other essential travel
• Workers responsible for operating dispatching passenger, commuter and freight trains and
public transportation and buses and maintaining rail and transit infrastructure and equipment
• Maritime transportation workers - port workers, mariners, equipment operators
• Truck drivers who haul hazardous and waste materials to support critical infrastructure,
capabilities, functions, and services
• Automotive repair and maintenance facilities
• Workers who respond to and clear traffic crashes, including contracted vendors and dispatchers
• Manufacturers and distributors (to include service centers and related operations) of packaging
materials, pallets, crates, containers, and other supplies needed to support manufacturing,
packaging staging and distribution operations
• Postal and shipping workers, to include private companies
• Workers who support moving and storage services
• Employees who repair and maintain vehicles, aircraft, rail equipment, marine vessels, and the
equipment and infrastructure that enables operations that encompass movement of cargo and
• Air transportation employees, including air traffic controllers, ramp personnel, aviation security,
and aviation management and other workers – including contracted vendors – providing
services for air passengers
• Workers who support the maintenance and operation of cargo by air transportation, including
flight crews, maintenance, airport operations, and other on- and off- airport facilities workers
COVID-19 Essential Services
March 23, 2020
• Workers who support the operation, inspection, and maintenance of essential dams, locks and
• Workers who support the operation, inspection, and maintenance of essential public works
facilities and operations, including roads and bridges, water and sewer main breaks, fleet
maintenance personnel, construction of critical or strategic infrastructure, traffic signal
maintenance, emergency location services for buried utilities, maintenance of digital systems
infrastructure supporting public works operations, and other emergent issues
• Workers – including contracted vendors – involved in the construction of critical or strategic
infrastructure including public works construction, airport operations, water, sewer, gas,
electrical, nuclear, oil refining and other critical energy services, roads and highways, public
transportation, solid waste collection and removal, and internet, and telecommunications
systems (including the provision of essential global, national, and local infrastructure for
computing services)
• Workers such as plumbers, electricians, exterminators, inspectors and other service providers
who provide services that are necessary to maintaining the safety, sanitation, and essential
operation of residences, construction sites and projects, and needed facilities
• Support, such as road and line clearing and utility relocation, to ensure the availability of needed
facilities, transportation, energy and communications
• Support to ensure the effective removal, storage, and disposal of residential and commercial
solid waste and hazardous waste
• Licensed site clean-up professionals and other workers addressing hazardous spills, waste sites,
and remediation.
• Workers who support the operation, maintenance and public safety of state parks, forests,
wildlife management areas, water supply protection lands, and other critical natural resources.
• Workers who support storm clean-up operations (e.g., foresters).
• Maintenance of communications infrastructure- including privately owned and maintained
communication systems- supported by technicians, operators, call-centers, wireline and wireless
providers, cable service providers, satellite operations, undersea cable landing stations, Internet
Exchange Points, and manufacturers and distributors of communications equipment
• Workers who support radio, television, and media service, including, but not limited to front line
news reporters, studio, and technicians for newsgathering and reporting
• Workers at Independent System Operators and Regional Transmission Organizations, and
Network Operations staff, engineers and/or technicians to manage the network or operate
• Engineers, technicians and associated personnel responsible for infrastructure construction and
restoration, including contractors for construction and engineering of fiber optic cables
• Installation, maintenance and repair technicians that establish, support or repair service as
• Central office personnel to maintain and operate central office, data centers, and other network
office facilities
• Customer service and support staff, including managed and professional services as well as
remote providers of support to transitioning employees to set up and maintain home offices,
COVID-19 Essential Services
March 23, 2020
who interface with customers to manage or support service environments and security issues,
including payroll, billing, fraud, and troubleshooting
• Dispatchers involved with service repair and restoration
Information Technology:
• Workers who support command centers, including, but not limited to Network Operations
Command Center, Broadcast Operations Control Center and Security Operations Command
• Data center operators, including system administrators, HVAC & electrical engineers, security
personnel, IT managers, data transfer solutions engineers, software and hardware engineers,
and database administrators
• Client service centers, field engineers, and other technicians supporting critical infrastructure, as
well as manufacturers and supply chain vendors that provide hardware and software, and
information technology equipment (to include microelectronics and semiconductors) for critical
• Workers responding to cyber incidents involving critical infrastructure, including medical
facilities, SLTT governments and federal facilities, energy and utilities, and banks and financial
institutions, and other critical infrastructure categories and personnel
• Workers supporting the provision of essential global, national and local infrastructure for
computing services (incl. cloud computing services), business infrastructure, web-based services,
and critical manufacturing
• Workers supporting communications systems and information technology used by law
enforcement, public safety, medical, energy and other critical industries
• Support required for continuity of services, including janitorial/cleaning personnel
• Workers to ensure continuity of building functions, including local and state inspectors and
administrative support of inspection services who are responsible for the inspection of
elevators, escalators, lifts, buildings, plumbing and gas fitting, electrical work, and other safety
related professional work
• Security staff to maintain building access control and physical security measures
• Elections personnel
• Federal, State, and Local, Tribal, and Territorial employees who support Mission Essential
Functions and communications networks
• Trade Officials (FTA negotiators; international data flow administrators)
• Weather forecasters
• Workers that maintain digital systems infrastructure supporting other critical government
• Workers at operations centers necessary to maintain other essential functions
• Workers who support necessary credentialing, vetting and licensing operations for
transportation workers including holders of Commercial Drivers Licenses
• Workers who are critical to facilitating trade in support of the national, state and local
emergency response supply chain
• Educators and staff supporting public and private emergency childcare programs, residential
schools for students with disabilities, K-12 schools, colleges, and universities for purposes of
facilitating distance learning, provision of school meals, or performing other essential student
support functions, if operating under rules for social distancing
COVID-19 Essential Services
March 23, 2020
• Hotel workers
• Critical government workers, as defined by the employer and consistent with Continuity of
Operations Plans
• Construction Workers who support the construction, operation, inspection, and maintenance of
construction sites and construction projects (including housing construction)
• Workers that provide services for or determine eligibility for public benefits such as subsidized
health care, food and feeding programs, residential and congregate care programs, shelter, inhome
supportive services, child welfare, juvenile justice programs, adult protective services and
social services, and other necessities of life for economically disadvantaged or otherwise needy
individuals (including family members)
• Workers in sober homes
• Professional services (such as legal and accounting services) and payroll and employee benefit
services, when necessary to assist in compliance with legally mandated activities and critical
sector services or where failure to provide such services during the time of the order would
result in significant prejudice
• Commercial retail stores that supply essential sectors, including convenience stores, pet supply
stores, auto supplies and repair, hardware and home improvement, and home appliance
• Laundromats and laundry services
• Workers and instructors supporting academies and training facilities and courses for the
purpose of graduating students and cadets that comprise the essential workforce for all
identified critical sectors
• Workers at places of worship
• Workers necessary for the manufacturing of materials and products needed for medical supply
chains including personal protective equipment and hygiene products, transportation, energy,
communications, food and agriculture, chemical manufacturing, nuclear facilities, the operation
of dams, water and wastewater treatment, emergency services, and the defense industrial base.
• Workers at nuclear facilities, workers managing medical waste, workers managing waste from
pharmaceuticals and medical material production, and workers at laboratories processing test
• Workers who support hazardous materials response and cleanup
• Workers who maintain digital systems infrastructure supporting hazardous materials
management operations
• Workers who are needed to process and maintain systems for processing financial transactions
and services (e.g., payment, clearing, and settlement; wholesale funding; insurance services; and
capital markets activities)
• Workers who are needed to provide consumer access to banking and lending services, including
ATMs, and to move currency and payments (e.g., armored cash carriers)
• Workers who support financial operations, such as those staffing data and security operations
COVID-19 Essential Services
March 23, 2020
• Workers supporting the chemical and industrial gas supply chains, including workers at chemical
manufacturing plants, workers in laboratories, workers at distribution facilities, workers who
transport basic raw chemical materials to the producers of industrial and consumer goods,
including hand sanitizers, food and food additives, pharmaceuticals, textiles, and paper
• Workers supporting the safe transportation of chemicals, including those supporting tank truck
cleaning facilities and workers who manufacture packaging items
• Workers supporting the production of protective cleaning and medical solutions, personal
protective equipment, and packaging that prevents the contamination of food, water, medicine,
among others essential products
• Workers supporting the operation and maintenance of facilities (particularly those with high risk
chemicals and/or sites that cannot be shut down) whose work cannot be done remotely and
requires the presence of highly trained personnel to ensure safe operations, including plant
contract workers who provide inspections
• Workers who support the production and transportation of chlorine and alkali manufacturing,
single-use plastics, and packaging that prevents the contamination or supports the continued
manufacture of food, water, medicine, and other essential products, including glass container
• Workers who support the essential services required to meet national security commitments to
the federal government and U.S. Military. These individuals, include but are not limited to,
aerospace; mechanical and software engineers, manufacturing/production workers; IT support;
security staff; security personnel; intelligence support, aircraft and weapon system mechanics
and maintainers
• Personnel working for companies, and their subcontractors, who perform under contract to the
Department of Defense providing materials and services to the Department of Defense, and
government-owned/contractor-operated and government-owned/government-operated
If the function of your business is not listed above, but you believe that it is essential or it is an entity
providing essential services or functions, you may request designation as an essential business.
Requests by businesses to be designated an essential function should only be made if they are NOT
covered by the guidance.
To request designation as an essential business, please click here:
Any questions can be directed to

From BMC Communications: COVID-19 Updates; 3/13 @ 8:09 AM

March 13th, 2020 in Uncategorized


Dear Colleagues,
Please read below for today’s updates.

A Note about Mask Usage and Conservation
No employee should have a mask on as they walk through the hospital unless they are caring for a patient on precautions in that patient’s room, or are transporting a patient on precautions. We need everyone’s help to conserve our supplies.
Updated Visitor Policy and Hospital Access Changes for Patients, Visitors, and Staff
An earlier update<> outlined our updated visitor policy (one visitor per patient at a time, no visitors under 18, no PACU visitors) as well as our plan to limit access points to the hospital.
NEW: Guidance for Care and Placement of Patients with Viral Respiratory Illnesses
In light of new guidance<> from the CDC, effective immediately BMC has updated its own infection control recommendations surrounding the care of patients with COVID-19. These new guidelines are designed to protect the safety of our employees, while ensuring we are able to continue to provide excellent care to our patients during an ongoing epidemic. It will also ensure staff are protected from unsuspected initial presentations of COVID-19 patients. They are consistent with what other academic medical centers have adopted.

Below is a summary of the changes. More detailed procedures will be shared as they are developed.

1) All patients with symptoms consistent with any viral respiratory illnesses (including suspected or confirmed COVID-19 cases)

COVID-19 Information; 3/12/2020 @ 6:56 AM

March 12th, 2020 in Uncategorized

Boston University Medical Campus
Office of the Associate Provost GMS

Dear GMS Faculty, Staff, and Students,

Today’s letters from President Brown is the university’s response to the COVID-19 pandemic and how we will make adjustments in the interests of all our BU community members. The change to remote teaching will begin next Monday (March 16th) and I applaud all of you who planned ahead for this transition. Note that EdMedia is a continuing resource and GMS has staff who can assist with Zoom as well. Contacts are on the GMS web page and feel free to reach out to us for help.

There are some points in President Brown’s communications that are under discussion and many people are asking questions. I do not have all the answers now. Generally, keep academic activities to groups of 10 people or less. If it is not essential, either cancel or do it remotely. However, the campus is still “open” so faculty and staff are expected to come to work as usual.

Research Graduate Students and Postdoctoral Scholars: Research activities will continue normally. Research graduate students should report to their research laboratories for rotations or thesis research, but do so with common sense. Talk with your PI to see if you can shift hours so you avoid rush hour on public transportation, freeze down cells, back up your data, try not to schedule long-term experiments with animals. You should follow the decisions and recommendations of your research PI. PhD thesis defenses can go on as scheduled, but limit attendance to 10 or fewer people. Avoid inviting family and plan your (anticipated) celebration at an off campus site to accommodate well-wishers.

Clinical Graduate Students: We hope that the status of clinical rotations will be resolved tomorrow morning at a meeting of BU deans. There is universal understanding of the potential impact on accreditation and graduation requirements and we are doing everything possible on behalf of our students. This is evolving very rapidly and I will keep you updated as soon as possible.

I appreciate your concerns and forbearance as we work through these changes. We still have a few days until the changes come into effect and I am very optimistic that matters will be worked out in time. These are extraordinary times and we are extraordinarily resilient.

With best regards,

Deborah Stearns-Kurosawa, PhD
Associate Provost ad interim
Graduate Medical Sciences
Make a Difference at GMS<

COVID-19 Information; 3/12/2020 @ 6:54 AM

March 12th, 2020 in Uncategorized

Dear Colleagues:

Study teams should be thinking about possible disruptions as a result of the COVID 19 novel coronavirus.  The IRB has posted a set of
FAQs that will be updated frequently.  You can also contact the IRB at or 617-358-5372.


John F. Ennever MD, PhD, CIP

Director, Office of Human Research Affairs


COVID-19 Notice; 03/12/2020 @6:53 AM

March 12th, 2020 in Uncategorized


To: BUSM Faculty, Staff and Students
From: Karen Antman, MD, BUMC Provost and BUSM Dean
Date: March 11, 2020
Re: COVID-19 Update

BU President Brown's letter today explains the University’s response to the COVID-19 pandemic.

All non-clinical teaching will be online from March 16 through at least April 13, 2020.  Third- and fourth-year MD Students on clinical rotations will continue to report for their hospital/clinic rotations or office-based assignments. At this time, students should not provide direct care to patients with presumptive or confirmed COVID-19 at any clinical site (to conserve Personal Protective Equipment for appropriately trained personnel required to care for these patients and to minimize unnecessary exposure). Such patients are identified by the hospital/clinic in which you are rotating, and will be appropriately isolated.

All domestic and international travel supported by funds administered by the University is suspended for faculty, staff and students.

Because we are a medical campus, personal domestic and international air travel is strongly discouraged. If you visit or travel through countries on the CDC restricted countries list at the time of your return, you must self-isolate for 14 days.

Day-to-day, routine staff business and research activity will continue under the new University guidelines.

See FAQs related to these changes here.

Thank you for your cooperation and attention. If you have any concerns, please contact me at



This electronic transmission may contain information that is privileged, confidential and exempt from disclosure under applicable law. If you are not the intended recipient, please notify me immediately as use of this information is strictly prohibited.

COVID-19 News

March 11th, 2020 in Uncategorized

Boston University Office of the President

One Silber Way
Boston, Massachusetts 02215

March 11, 2020
Dear Friends,
Over the past few months, our leadership team has closely monitored the growing impact of the coronavirus (COVID-19) outbreak both internationally and locally. Our first priority is to ensure the health and well-being of our community, while also making sure that our students are able to complete their courses and advance their progress toward graduation, while preparing contingencies to ensure the functioning of our campus operations.
Due to the increased spread of the coronavirus throughout the United States and around the world, we have decided to make the following changes, effective Monday, March 16, 2020 until Monday, April 13, 2020:
  1. Undergraduate, graduate, and BU Academy classes on the Charles River and Medical Campuses will not meet in-person; course content and instruction will be moved online and classes will meet remotely at their regularly scheduled times. Students with questions about courses or academic accommodations should contact their professors directly.
  2. We strongly advise that students who are not presently on campus do not return to campus at the conclusion of spring break. We have a large number of students on campus during the break, and we encourage those students to consider going home, if possible. However, our residences and dining halls will remain open during this period for those who choose to stay on campus or are unable to return to their homes.
  3. The University will not hold any non-academic gatherings or meetings; only activities for research with fewer than 10 participants will be permitted.
  4. All domestic and international travel by faculty, staff, and students, supported by funds administered by the University, is suspended.
At this time, we are planning that research activity will proceed normally under the guidelines described above. Additional information about the impact to other University operations will be communicated to University staff in a separate memo. Decisions about Study Abroad programs are being made on a site-by-site basis; questions about a particular Study Abroad program can be sent to
We ask that staff supervisors work with members of their unit to assess their capability of working remotely during the period defined above. It is our hope that we can accommodate staff who would rather not come to campus, but who can accomplish their responsibilities from home.
We will provide regular updates to these plans over the coming weeks. Well in advance of April 13, we will announce to the community the plans for the remainder of the semester. Regular updates and additional information on the University’s response to the COVID-19 outbreak will be available on this website.
Discontinuing in-person instruction is a difficult decision, as it interrupts an essential element of our learning community, the interactions that occur in our classrooms, laboratories, and studios. We recognize that this will cause significant disappointment to many students, faculty, and staff. However, our first priority must be to keep the members of our community as safe as possible.
We also know that the transition to online teaching in the middle of a semester is a challenge, and we are committed to providing the necessary resources to equip all faculty for success in this mode of delivery. Through our Remote Teaching Readiness Plan, schools and colleges have already begun preparing. We encourage faculty to contact their school or college’s Remote Teaching Coordinator (RTC) with questions about migrating course content online. We also encourage instructors to email students in their courses before Monday, March 16, to alert them to the class plan for the next week.
To learn about working and teaching remotely, visit the IS&T website or contact (regarding working remotely) or (regarding teaching remotely). Resources for students about learning remotely can also be found on the IS&T website.
Finally, we are developing and will shortly distribute a set of Guidelines for Semester Completion to help faculty and staff think through how to ensure students are able to complete their scheduled coursework this semester.
We appreciate all the work that has already been done to prepare our community for this possibility, from our emergency management and health services teams to the facilities teams ensuring that our campuses remain as clean as possible, and we are grateful for all that each of you will do over the coming weeks to adapt to these changes. We are convinced that the Boston University community will come through this trying period stronger than ever, and we look forward to having everyone back on our campuses as soon as possible.
Additional Resources
You may find these additional resources useful.
For international students and scholars with questions about travel, please contact the International Students & Scholars Office at or 617-353-3565.
For questions about Study Abroad, please contact
For students’ questions regarding financial situations, please contact the University Service Center at or 617-358-1818.
For those with medical questions or concerns about COVID-19, contact the applicable on-campus health centers listed below for more information.
For students:
Student Health Services, follow instructions to send a message to a nurse.
For employees:
Boston University Occupational Health Center at 617-353-6630
Robert A. Brown
Jean Morrison
University Provost and Chief Academic Officer

Pathology & Laboratory Medicine News Items – Winter 2019-2020

January 31st, 2020 in Uncategorized


Pathology & Laboratory Medicine News Items – Winter 2019-2020



  • Liz Duffy, MA has been appointed our new Masters Graduate Program Director
  • Beverley Orr, MT (ASCP) has accepted the position and role of Operations Director for Pathology & Laboratory Medicine effective Feb 3rd, 2020.

Amanda Araujo, almost MS graduate, gave a presentation in October at the Society for Neuroscience Conference in Chicago, Illinois entitled “Visualization and assessment of stellate ganglia neuronal remodeling in association with myocardial infarction (MI) and coronary artery disease.” Authors: AG Araujo, D. Park, KS Steed, OA Ajijola, K. Shivkumar, A. Mahajan, M. Fishbein, N. Hageman, E. Stack, JJ Wisco






Also for Amanda, the following second paper has been accepted for publication. Bravo Amanda!!: Stephen G. Cieslak, BreAnna Hutchinson, Rajan Adhikari, Kevin S. Steed, Ryan S. Staudte, Parker Cox, Abbey Rasch, Elizabeth Black, Amanda Araujo, Jonathan J. Wisco. “The Effects of L-Cysteine on Alzheimer’s Disease Pathology in APOE2, APOE3 and APOE4 Homogeneous Mice” Journal Brain and Nerves

Amanda, graduating in May, has also recently accepted a position at Massachusetts General Hospital as an Anatomic Pathology Specialist

Daniel Remick, M.D. was an Invited Speaker to give a presentation at the 18th European Shock Society in Crete titled “Hydrocortisone, Ascorbic Acid and Thiamine treatment for sepsis” on October 10th & 11th 2019

Also for Dr. Remick:

  • Dr. Remick was a Moderator at the 18th European Shock Society session on Novel Pathomechanisms and Therapeutics in Critical Care, Chania, Greece
  • Dr. Remick also participant in the Wiggers-Bernard Workshop on Animal Models of Sepsis

Both Dr. Carmen Sarita-Reyes and Dr. Grace Zhao passed their pathology Continuing Certification (CC) examination

  • Dr. Grace Zhao: Continuing Certification (CC) examination in Anatomic Pathology and Clinical Pathology
  • Dr. Carmen D. Sarita-Reyes: Continuing Certification (CC) examination in Anatomic Pathology and Clinical Pathology and Pediatric Pathology

Professor Emeritus Hugues Ryser passed away Jan. 24. Dr. Ryser was a member of our department and Professor of Pathology and Pharmacology from 1972-2003. He also held appointments as a Professor of Public Health and Socio-Medical Sciences and Community Medicine, and Biochemistry at BUSM. He was the recipient of the St. George National Award, in recognition of distinguished service for significant impact on the American Cancer Society’s strategic goals and mission-driven programs in 1996. He was also nominated a fellow of the American Association for the Advancement of Science.

Dr. Ryser was born in Switzerland in 1926. He received his Swiss medical degree (1953) and his Dr Med degree (1955) from the University of Bern before working in the Department of Medicine at University Hospital in Lausanne. In 1958 Dr. Ryser moved to Mass General Hospital and then to Harvard Medical School, where he remained for more than 10 years, becoming a faculty member in the Pharmacology Department. He subsequently moved to the Washington/Baltimore area to pursue research in Cell and Molecular Biology and Pharmacology before returning to Boston to become Professor of Pathology and Pharmacology at Boston University School of Medicine in 1972. Dr. Ryser held faculty appointments as well in the Departments of Public Health and Socio-Medical Sciences and Community Medicine (Environmental Health) and in Biochemistry at BUSM. While working here, Dr. Ryser and wife Dr. Carol Ryser (d. 2012), moved to Concord, Mass., where they raised a family and continued to live for the remainder of their lives. 

Dr. Ryser was an intellectually curious person. His broad background in medicine, pharmacology, pathology, cell biology and biochemistry led him to explore challenging questions over 50 years of research and teaching resulting in more than 100 peer reviewed articles and abstracts. His later work contributed to elucidating the mechanisms by which HIV is able to enter human cells. Dr. Ryser also served on many national and international organizations committed to improving the quality and breadth of research in the United States. He was a strong supporter of young researchers. As president of the Boston Cancer Research Association he helped provide funding to future cancer researchers in the New England area. He never hesitated to support women in science and medicine, even when this was not common practice. Dr. Ryser was strongly committed to biomedical research and teaching. At the same time, he was a lover of French food and French culture and was a beloved husband, father and grandfather. He will be missed by many at BUMC who knew him well.



  • Mostafa Belghasem, Daniel M Roth , Sean Richards , Marc Arthur Napoleon , Joshua A Walker , Wenqing Yin , Nkiruka Arinze , Chimera Lynn Lyle , Cheryl Anne Spencer , Jean Francis , Cristal Reyna Thompson , Christopher Andry , Stephen A. Whelan , Norman Lee , Katya Ravid , Vipul Chitalia. “Metabolites in a Mouse Cancer Model Enhance Venous Thrombogenicity Through Aryl Hydrocarbon Receptor-Tissue Factor Axis.” Accepted Nov. 5th for publication in BLOOD (Impact factor 16.5)


Pathology & Laboratory Medicine News Items – Fall 2019

October 22nd, 2019 in Uncategorized

Pathology & Laboratory Medicine News Items – Fall 2019




  • New Faculty Member Dr. Sara Higgins
  • We have a new joint NEIDL/Ex+ histotechnologist, Hans Gertje. Dr. Nick Crossland says they are thrilled to have him on board as our histology supervisor as we begin our BSL4 animal experiments at the NEIDL Hans is a graduate of Washington State University with a B.S. in Genetics and Cell Biology. He is an ASCP certified Histotechnologist with five years of industry experience in clinical and research laboratories, with focus on developing companion diagnostic marker assays and multiplex IHC panels. Hans lives in Saugus, MA with his wife and dog, and is expecting a daughter in October. In his free time he enjoys hiking with his family and watching football


  • Dr Ivana Delalle will be leaving and joining the Alpert Medical School of Brown University faculty of Pathology and Laboratory Medicine on November 1, 2019 as the Director of Neuropathology at Brown and Lifespan Academic Medical Center, The Miriam and Rhode Island Hospitals. Dr Delalle was a highly valued member of our department and the BMC and BUSM community at large for 15 years. She will remain as adjunct faculty in the department.
  • Dr Mostafa Belghasem will be leaving to serve as an Assistant Professor and biomedical science educator and pathology content expert at the Kaiser Permanente School of Medicine in Pasadena CA. Dr Belghasem has been a wonderful, innovative educator, scientist and administrator for our department, he will remain as an adjunct faculty member with us.

We all wish both colleagues good luck and success with their new opportunities

 Nancy S. Miller, MD was an invited speaker at two State venues:

  • 1) The Massachusetts State Public Health Laboratory, Bureau of Infectious Disease and Laboratory Sciences (9/5; The impact of the opioid crisis on the clinical microbiology laboratory)
  • 2) The Office of the Chief Medical Examiner (9/11; Postmortem/Forensic Microbiology Update)

Dr. Dennis Jones has been named the Ralph Edwards Career Development Professor:\

Dr. Nicholas Crossland was awarded an NIH Shared Instrument Grant S10D026983-01 entitled “Ventana Discovery Ultra Research Auostainer”. This equipment will be managed by the Ex+ laboratory and offered as a core service. This machine performs an array of highly multiplexed tissue and cell based assays including both chromogenic and fluorescent immunohistochemistry and in situ hybridization. The success of this proposal reflects a multi-departmental collaboration that includes the following research laboratories in no particular order: Drs. Blusztajn, Chitalia, Remick, Senoo, Sahin-Toth, Jones, Wolozin, Rock, Colpitts, Ikezu, Kramnik, Duprex, Kurosawas, Haydar, Davey, Griffiths, and Mühlberger

Teresa Russell and Elysia Heiling, Masters Students working with Dr. Mostafa Belghasem, both have been selected to participate in the Kidney STARS 2019 trainees program organized by the American Society of Nephrology (ASN). Tersa and Elysia also received a travel grant from ASN to attend Kidney Week 2019

Dr. Ivana Delalle was invited to present a keynote lecture in the Presidential Symposium of the Croatian Neuroscience Meeting, September 12-15, Zadar, Croatia: Her lecture was entitled: "GWAS-identified Alzheimer’s disease risk variants - lessons from neuropathology"

Pathology Resident, Dr. Shoreh Fazeli presented a poster at 31st European Congress of Pathology held in Nice, France on September 11th. Title and authors: “May lesion size impact recognition of biologically aggressive noninvasive follicular thyroid neoplasm with papillary-like nuclear features? Meta-analysis”. Israa Laklouk, Shoreh R Fazeli, Reyhan Gedik, Sandra Cerda


Dr. Shoreh Fazeli at the 31st European Congress of Pathology held in Nice, France




Morgan Thompson, MS gave a poster presentation this past weekend: “Consenting Challenges toward Age, Ethnicity, and Co-Morbidity Matching of Cancer Patient and Control Populations at a Diverse Safety Net Hospital”. American Association for Cancer Research (AACR) Conference for Health Disparities, San Francisco, CA; Sept 20, 2019



Morgan Thompson, MS, at the American Association for Cancer Research (AACR) Conference for Health Disparities, San Francisco, CA




David Sherr, PhD  gave a plenary talk at the International Dioxin 2019 meeting in Kyoto, Japan.

Dr. Sherr also recently received an R01 entitled “AHR-mediated immunosuppression in glioblastoma”


  • Jain G, Stündl A, Rao P, Berulava T, Pena Centeno T, Kaurani L, Burkhardt S, Delalle I, Kornhuber J, Hüll M, Maier W, Peters O, Esselmann H, Wiltfang J, Mollenhauer B, Maetzler W, Schneider A, Fischer A: A combined miRNA-piRNA signature to detect Alzheimer’s disease. (Accepted for publication in Translational Psychiatry)
  • Canter RG, Choi H, Huang W-C, Wang J, Watson LA, Yao CG, Abdurrob F, Bousleiman SM, Young JZ, Bennet DA, Delalle I*, Chung K*, Tsai L-H* (*corresponding authors): 3D Mapping Reveals Network-specific Amyloid Progression and Subcortical Susceptibility. (Accepted for publication in Communications Biology)